Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Characterization of the Partition Rate of 2-Naphthol (NAP) and Ritonavir (RTV) Across the Water-Octanol Interface and the Influence of Common Pharmaceutical Excipients.

Journal of pharmaceutical sciences·2020
Same author

Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2020
Same author

Simultaneous Full-Color Printing and Holography Enabled by Centimeter-Scale Plasmonic Metasurfaces.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2020
Same author

Surfactant-laden bubble dynamics under porous polymer films.

Journal of colloid and interface science·2020
Same author

Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.

Cancer biotherapy & radiopharmaceuticals·2020
Same author

Succinate induces skeletal muscle fiber remodeling via SUCNR1 signaling.

EMBO reports·2020

相关实验视频

Updated: Jun 27, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

适应性两阶段无顺序设计用于临床试验.

Ping Gao1, Yingqiu Li2

  • 1Biostatistics, Innovatio Statistics, Inc ., Bridgewater, USA.

Journal of biopharmaceutical statistics
|May 5, 2024
PubMed
概括

本研究引入了临床试验的灵活适应性顺序测试方法,允许适应性治疗选择和样本大小调整. 这种方法提高了多选项药物开发和测试的效率.

科学领域:

  • 生物统计学 生物统计学
  • 临床试验设计 临床试验设计
  • 药学研究 药学研究

背景情况:

  • 传统的临床试验设计往往缺乏选择和测试多种治疗方案的灵活性.
  • 预先规定的选择规则可能会限制适应新出现的疗效和安全数据的能力.

研究的目的:

  • 为组合II/III期试验提出一个适应性的测试程序.
  • 根据不断变化的数据来灵活选择治疗方案,而不仅限于"最佳"选择.
  • 为了为这种自适应设计提供准确的样本大小和功率计算.

主要方法:

  • 为选择和测试多种治疗方案,开发了一种自适应的顺序测试程序.
  • 该程序允许在第二阶段结束时使用灵活的,未预先规定的选择规则.
  • 为样本大小,功率和推断 (p值,置信区间) 提供统计方法,并通过模拟进行验证.

主要成果:

  • 样本大小和功率计算通过模拟证实准确.
  • 该程序包括选拔后的中间分析和样本大小修改.
  • 该方法适用于各种终点分布,包括正常,二进制,波桑,负二项式和时间到事件数据,以及它们的混合.

结论:

关键词:
布朗的运动近似.适应性的两个阶段的顺序设计.无组合的无组合.治疗选择,治疗选择.

更多相关视频

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

503
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

相关实验视频

Last Updated: Jun 27, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

503
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
  • 拟议的自适应序列测试程序为具有多种治疗选择的临床试验提供了灵活和高效的方法.
  • 这种方法允许研究人员根据疗效和安全数据调整试验行为,改善决策.
  • 该程序在不同终点类型的广泛适用性支持其在各种制药研究环境中的实用性.